Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial.

Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial.

Item
http://www.wikidata.org/entity/Q34049802
Treatment of relapsed and refractory multiple myelomaPrevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis.The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology.Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.Multiple myeloma in the older adult: better prospects, more challenges.Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials.Advances in targeted therapy for the treatment of patients with relapsed/refractory multiple myeloma.Long-term health-related quality of life in transplant-ineligible patients with newly diagnosed multiple myeloma receiving lenalidomide and dexamethasone.Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia.Health-related quality of life in patients with multiple myeloma--does it matter?
P2860

Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial.

Item
http://www.wikidata.org/entity/Q34049802
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Factors that influence health- ...... results of a randomized trial.
@ast
Factors that influence health- ...... results of a randomized trial.
@en
Factors that influence health- ...... results of a randomized trial.
@nl
type
label
Factors that influence health- ...... results of a randomized trial.
@ast
Factors that influence health- ...... results of a randomized trial.
@en
Factors that influence health- ...... results of a randomized trial.
@nl
prefLabel
Factors that influence health- ...... results of a randomized trial.
@ast
Factors that influence health- ...... results of a randomized trial.
@en
Factors that influence health- ...... results of a randomized trial.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Factors that influence health- ...... results of a randomized trial.
@en
P2093
P2860
P304
P31
P356
10.3109/10428194.2013.847933
P433
P478
P50
P577
P5875
P698
P921
P932